In the inflammatory bowel disease (IBD) induced by LPS in human colon mucosal epithelial cells (NCM460), Mor reduced apoptosis, inflammation, and oxidative stress by regulating Bax/Bcl-2, inhibiting TNF-α, IL-1β, IL-6, SOD, MDA, T-AOC, and MPO levels. Here, MPO is linked to inflammatory bowel disease.